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                                              ABBREVIATIONS 
GFR                -Glomerular filtration rate  
C-G                 -Cockcroft-Gault 
MDRD            -Modification of Diet in Renal Disease 
CKD                -Chronic kidney disease 
AKI                 -Acute kidney injury 
CKD-EPI        -Chronic kidney disease – epidemiology collaboration 
CrCL               -Creatinine clearance 
DTPA             -Diethylene triamine pentaacetic acid  
EDTA             -Ethylene diamino tetra-acetic acid 
e GFR             -Estimated GFR 
ESRD             -End stage renal disease 
CVD               -Cardio vascular disease 
Tc 99              -Technetium 99 
K/DOQI         - Kidney disease outcome quality initiative 
 
 
INTRODUCTION 
 
CKD progresses into end stage renal disease (ESRD) inspite of our 
strategies to slow the progression of the disease .ESRD occurs when 
kidney function is  not able to cope up with the  body’s excretory load  and 
hemodialysis, peritoneal dialysis ,or  kidney transplantation has to be  
substituted for native kidney function. Among them, kidney transplantation 
by far imparts a better quality of life in ESRD patients. 
The shortage of donor organs is a global issue, that restrict kidney 
transplantation. Hence patients and transplant surgeons are increasingly 
dependent on live kidney donors. Although kidney transplantation offers a 
favourable outcome for the recipient, it may be associated with some risk 
for the donor. To minimize the risks a strict pre-operative donor evaluation 
is essential. 
Renal function assessment  of the  donor is the most important part  
of donor evaluation. Glomerular filtration  rate  (GFR) is  considered to be 
optimal test for overall assessment of renal function but serum creatinine is 
not considered as appropriate and only measurement of renal function, 
especially for detection ofearly stages of CKD due to its tubular secretion
[1]
 
and also its variability with body mass , age, sex and race. 
It is well known that GFR can be precisely measured by specific 
filtration  markers such as Inulin,I125 Iothalamate,Cr 51 EDTA,Tc99-
diethylene triamino  penta acetic acid (DTPA).These standard methods 
cannot  be used in daily clinical practice unfortunately  as they are 
expensive, time consuming and cumbersome and require specialized 
equipments and skills. 
So a non invasive and accurate estimation of GFR is the need of the 
hour in Nephrology. Here comes the GFR prediction equations which are 
easy to apply, cost effective and less cumbersome. The new K/DOQI 
Guidelines also recommend estimating GFR by MDRD and 
COCKCROFT-GAULT equations
.[2]
 
Hence, it sounds worthy for me to take up this comparative study of 
GFR calculation by COCKCROFT-GAULT formula, MDRD formula, 
CKD-EPI formula and DTPA renal scan among live  related  kidney 
donors . 
 
 
 
 
  
AIMS AND OBJECTIVES 
1) To  estimate GFR by 3 different methods namely COCKCROFT-
GAULT formula,MDRD formula and CKD-EPI formula ,among 
live related kidney donors . 
2) To analyse how closely the GFR calculated by these formulae 
correlate with that of DTPA renal scan in them. 
 
 
 
 
 
 
 
 
 
                               
                            
                        REVIEW  OF LITERATURE 
 
      RENAL PHYSIOLOGY: 
Glomerular filtration rate (GFR) is a product of average filtration 
rate of each single nephron, the filtering unit of the kidneys, multiplied by 
number of nephrons in both kidneys 
[1].
It  is the volume of fluid filtered 
from renal glomerular capillaries into Bowman’s capsule per unit time. 
The normal level for GFR is approximately 130ml/min per 1.73m
2
 for men 
and 120ml/min per 1.73m
2
 for women. This varies according to age, sex, 
body size, physical activity, diet, pregnancy
[5]
  and drug intake.GFR is 
usually expressed per 1.73m
2
  for standardization. 
GFR  is 8% higher in young men than in women.GFR has a diurnal 
variation of 10% lower value at midnight. During  pregnancy GFR 
increases by 50% in first trimester and values normalizes after 
delivery.GFR falls gradually by 0.75ml/min/year after the age of 40 years. 
A fall in GFR can be due to  a decline in nephron number  or  a decline in 
single nephron GFR, but an increase in GFR can be due to increase in 
single nephron GFR or glomerular hypertrophy. Hence the level of  GFR 
do not indicate loss of nephrons  and GFR may remain within normal 
range  inspite of substantial kidney damage.   
GFR is calculated by using any chemical that has a steady level in 
the blood and is freely filtered but neither reabsorbed nor secreted by the 
kidneys. The rate hence measured is the quantity of the substance in urine 
that originated from a calculated volume of  blood
[3].
 
  The product of urine concentration and urine flow equals the mass 
of a substance excreted during the time that urine has been collected. This 
mass equals the mass filtered at the gomerulus as nothing is added or re-
absorbed  in nephron. When we divide this mass by plasma concentration 
we get the  volume of plasma from which the mass must have come from; 
and thus it gives volume of plasma fluid that has entered the Bowman’s 
capsule within that time period of time. 
GFR = (urine concentration × urine flow) / plasma 
concentration 
GFR is recorded in units of volume /time. 
MEASUREMENT OF GFR : 
GFR cannot be measured directly,  in clinical settings  it is measured as 
urinary clearance of an ideal filtration marker. 
THE CONCEPT OF CLEARANCE :  
Clearance of a substance is defined as the volume of plasma cleared of a 
marker by excretion per unit of time 
[1].
 It is a measure of the renal 
excretion ability. Each substance has a specific clearance that depends on 
its filtration characteristics. Clearance is a function of glomerular filtration, 
secretion from the peritubular capillaries to the nephron, and reabsorption 
from the nephron back to the peritubular capillaries. It doesnot represent an 
actual volume of plasma but a virtual volume of plasma that is completely 
cleared of the substance per unit of time. If the rate of elimination of a 
substance is high its clearance is also high. Clearance of a substance is the 
sum of urinary and extra  renal clearance. It has units of  Volume /time. 
URINARY CLEARANCE: 
Urinary clearance of a substance  x , (cx)  is defined as: 
       CX=(UX×V)/PX  
Where UX  -Urinary concentration; PX -plasma concentration; V-Urine 
flow rate 
An ideal filtration marker is one which is filtered freely, not secreted  
and not reabsorbed. If a substance is filtered and secreted ,urinary 
clearance is greater than GFR and if a substance is filtered and reabsorbed 
urinary clearance is lesser than GFR. 
PLASMA CLEARANCE: 
Plasma clearance of a substance x, (CX)   is defined as  
             CX = AX / Px 
Where AX is amount of marker administered and PX is plasma 
concentration . Plasma clearance of a substance also depends on filtration, 
tubular secretion, and tubular re-absorption and in addition extra renal 
elimination.      
PRESSURE DEFINITION OF GFR
:[4] 
GFR is the fluid flow rate between glomerular capillaries and bowmans 
capsule  
             dq/dt= Kf ×(Pg-Pb-πg+πb) 
dq/dt is the GFR 
Kf is the filtration constant and is defined as product of hydraulic 
conductivity and surface area of glomerular capillaries  
Pg is the hydrostatic pressure within the glomerular capillaries  
Pb is the hydrostatic pressure within bowmans capsule 
Πg is colloid osmotic pressure within glomerular capillaries 
Πb is colloid osmotic pressure within bowmans capsule  
MEASUREMENT OF RENAL PLASMA FLOW:  
The use of the clearance technique and the availability of substances 
that undergo both glomerular filtration and tubular secretion have made it 
possible to measure renal plasma flow (RPF). Paraamino hippuric acid 
(PAH) is an organic acid that is filtered by the glomerulus and actively 
secreted by the proximal tubule. The amount that is found in the final urine 
is the sum of the PAH filtered plus the component that is secreted.When 
the plasma concentration of PAH is lower than 10mg/dl, most of the PAH  
reaching the peri-tubular capillaries is cleared by tubular secretion and 
little PAH appears in renal venous plasma. Under these circumstances, the 
amount of PAH transferred from the plasma to the tubular lumen via 
filtration and secretion approximates the amount of PAH delivered to the 
kidneys in the plasma . 
Therefore, 
         RPF = (Upah × V) / Ppah 
Where Upah and Ppah are the concentrations of PAH in the urine and 
plasma, respectively and V is the urine flow rate.  
Renal blood flow ( RBF)  = (RPF / 100-Hematocrit) × 100 
The most important limitation of this method is the renal extraction of 
PAH. The latter is always less than 100%. At high plasma concentrations, 
fractional tubular secretions of PAH declines and  significant amount 
appear in the renal veins, under these circumstances, PAH clearance 
seriously under estimates RPF. 
AUTO REGULATION OF RENAL BLOOD FLOW AND GFR: 
  Acute variations in arterial blood pressure inevitably cause 
corresponding changes in RBF and GFR, these changes are short lived and 
provided the blood pressure remains within the normal range, 
compensatory mechanisms come into play after a few seconds to return 
both RBF and GFR to near normal. This phenomenon is called auto-
regulation .This is brought about by two different mechanisms: 
1) A myogenic reflex, whereby the afferent arteriolar smooth muscle 
wall constricts automatically when renal perfusion rises. 
2) Tubulo-glomerular feedback, whereby an increased delivery of Nacl 
to the macula  densa  region of nephron, resulting from increases in 
blood pressure RBF, and GFR, vasoconstriction of the afferent 
arteriole supplying that nephron’s  glomerulus  
These mechanisms restores both RBF and glomerular capillary pressure  
towards normal, the initial change in GFR is also reversed. But these auto 
regulatory mechanisms operate only within a mean arterial pressure range 
of  80 to 180 mmHg. 
 
 
MEASUREMENT OF GFR USING EXOGENOUS FILTRATION 
MARKERS : 
Inulin is polymer of fructose, historically described as the ideal 
filtration  marker  and was considered gold standard method in the past. 
GFR can be determined by injecting Inulin into plasma, allowed to achieve 
a steady state concentration and bladder is catheterised for strict urine 
collection. Since Inulin is neither reabsorbed nor secreted by kidney after 
glomerular filtration, its rate of excretion is directly proportional to the rate 
of water and solutes across glomerular filter. This method is cumbersome 
and not commonly used. Inulin clearance slightly overestimates GFR. In 
early stages of renal disease the inulin clearance may remain normal due to 
hyperfiltration in remaining nephrons. Due to these drawbacks alternative 
exogenous markers like iothalamate,  iohexol,  DTPA are used now. 
 
 
 
 
 
 
ENDOGENOUS FILTRATION MARKERS: 
Creatinine is frequently used endogenous filtration marker, urea and 
now cystatin–C are also used. The plasma level of a marker is related to 
the reciprocal of the level of GFR, but it is also influenced by eneration, 
tubular secretion, re-absorption and extra renal elimination collectively 
called as non-GFR determinants of the plasma level. In a steady state, a 
constant plasma level is maintained .   
CREATININE BASED GFR MEASUREMENT: 
Creatinine is produced naturally by the body. It is a break down product 
of Creatine phosphate, which is found in muscle. Other sources are dietary 
meat intake, or creatine supplements. Its production depends on muscle 
mass. It is freely filtered by the glomerulus, but actively secreted by the 
peritubular capillaries. Several medications inhibit this secretion and hence 
raising creatinine level. Creatinine  in intestinal secretion is degraded by 
bacteria, leading to low levels. In case of low GFR this extra renal 
excretion of creatinine is increased. Unlike precise GFR measurement 
involving constant infusion of inulin, creatinine is already at a steady state 
concentration in the blood and so measuring creatinine clearance is much 
less cumbersome . 
 However, creatinine estimates of GFR have their limitations. All of the 
estimating equations depend on a prediction of 24 hr creatinine excretion 
rate, which is a function of muscle mass. One of the equation 
COCKCROFT-GAULT do not correct for race. 
Creatinine synthesis depends on muscle mass. Cachectic patients and 
cirrhotic patients have low net muscle mass and lower creatinine excretion 
rate than predicted by equations. Hence a creatinine value of 1 mg/dl may 
appear normal but actually these patients may have renal failure. Similarly 
creatinine value of 1.5 may be normal in a obese individual      
 CREATININE CLEARANCE  (C Cr) :  
Creatinine clearance is calculated from creatinine concentration in 
collected  urine sample (UCr), urine flow rate (V) and creatinine 
concentration in  plasma  ( P Cr) 
                                 C Cr=   (U Cr × V) / P Cr 
 However creatinine  clearance  is not widely measured anymore due to  
1) Difficulty in assuring a complete urine collection 
2) Variability due to muscle mass, age, race, sex 
 
 
 
  
BIOSYNTHESIS AND METABOLISM OF CREATININE 
[6 ]  
 
 
                                        ( In kidney) 
                           Arginine-glycine transaminidase 
L-arginine                                                                        Glycocyanin 
                                                                                   ( guanido acetate ) 
                  glycine                             ornithine          ATP                    S-adenosyl 
                                                                                                              methionine 
                                                            Guanido-acetate 
                                                           Methyl transferase 
                                                                  (In liver)                             S-adenosyl 
                                                                                  ADP                    h.cysteine 
 
                                          ( Non enzymatic in muscle)                        
 Creatinine                                                                      creatine phosphate 
                                                                        
 
                                           Pi+H2O 
 
 
 
 FACTORS AFFECTING SERUM CREATININE 
CONCENTRATION
[7 ]
 
 
PARAMETERS EFFECT ON 
S.CREATININE 
MECHANISM 
Age Decreases Decreased creatinine production 
due to age related reduction in 
muscle mass 
Female sex Decreases Decreased creatinine production 
due to age related reduction in 
muscle mass 
African American 
race 
Increases Increased creatinine production 
due to high muscle mass 
Vegetarian diet Decreases Decreased creatinine production 
Dietarymeat,creatine 
supplements 
Increases Transient increase in creatinine 
generation 
Muscular 
individuals 
Increases Increased generation of 
creatinine and increased muscle 
protein 
Obesity No change Excess mass is only fat 
Trimethoprim, 
Cimetidine,fibrates 
Increases Reduced tubular secretion of 
creatinine 
Ketoacids, 
Cephalosporins 
Increases Interference withalkaline picrate 
assay for creatinine. 
 
 CREATININE ASSAY: 
In Jaffe’s assay  (alkaline picrate assay) chromogens are generated 
depending upon concentration of creatinine. Here main drawback is 
chromogens other than creatinine  gives  a false positive values.Modern 
enzymatic assays do not detect other chromogens. Due to heterogeneity in 
creatinine assays, global standardization of creatinine assays has to be 
enforced strictly.
[8]
 In  Ross et al study
[9]
, the average  coefficient of 
variation serum creatinine  in laboratories was 8% and 13%  
overestimation of values when compared to reference standard. 
ESTIMATED  GFR  USING  COCKCROFT-GAULT  FORMULA:  
 
            Crcl = 
                        
                      
                  
 
Thus  estimated  Creatinine  clearance using Cockcroft-gault formula 
depends on age, body weight, Sex
[10]
.
 
As age increases creatinine clearance 
decreases, and women have 15% lower creatinine clearance than men of 
same age and body weight. 
Limitations of this equation are : 
     -it is not  accurate  in cases where GFR is >  60ml/min 
     -it overestimates GFR 
     -it was derived by older creatinine assay methods 
     -drug dosing by this method is inaccurate , (Stevens et al 
[11]
 ) 
 
ESTIMATED GFR USING MDRD FORMULA: 
                 =                                                                                                    
                                                                  
 
          MDRD (Modification of diet renal disease) formula (6 variable) was 
initially introduced, with following parameters: age, race, sex, serum 
creatinine, blood urea, serum albumin. This formula was revised and 
reintroduced, MDRD (4 variable). Here the parameters are age, race, sex, 
serum creatinine
.[12 ]
 
Advantages of 4 variable MDRD over 6 variable MDRD are that it 
is better  validated in diabetic kidney disease, kidney transplant recipients 
and in African-Americans. MDRD  formula underestimates GFR in 
patients with  GFR more than 60.The  utility  of  MDRD formula has not 
been validated in children, in patients with serious co-morbid conditions, 
in healthy persons, or in individuals older than 70 years of age. It is also 
not validated in an acute kidney injury setting. Inspite of that, it is 
recommended for clinical assessment of kidney function
[13]
. Morethan 70% 
of labs in USA follows MDRD (American college of pathologists) 
[14 ].
Also 
MDRD is increasingly being used in all races and ethnic groups
[15]
. In 
august 2005 the Australasian creatinine consensus working group 
recommended that whenever serum creatinine estimation is requested  
GFR using MDRD may be given along with it, in patients aged over 18 
years.
[24]
 
ESTIMATED GFR USING CKD-EPI FORMULA: 
 =141 x min (SCr/k,1)a x max(SCr/k,1)-1.209  x 0.993age x [1.018 if female] x [1.159 if  
                                                                                                                           black ] 
                  
where SCr is serum creatinine  (mg/dL), k is 0.7 for females and 0.9 for 
males, a is -0.329 for females and -0.411 for males, min indicates the 
minimum of SCr/k or 1, and max indicates the maximum of SCr/k or 1. 
The CKD-EPI  (chronic kidney disease epidemiology collaboration ) 
formula was published recently in may 2009. It was developed in an effort 
to create a formula more accurate than the MDRD formula, especially 
when actual GFR is more than 60ml /1.73m2. Researchers pooled data 
from multiple studies, diverse clinical populations, to validate this new 
equation
[16]
. The CKD-EPI equation performed better than MDRD 
equation, with less bias and greater accuracy. It also resulted in restaging 
of the CKD patients who were staged according to the MDRD formula
[23]
. 
After introduction of  CKD-EPI, now GFR is reported for all ranges of the 
kidney function and CKD-EPI should replace MDRD equation for routine 
clinical use [John Feehaly].   
ESTIMATION OF GFR BY OTHER ENDOGENOUS MARKERS: 
UREA: 
 It is an end product of protein catabolism by the liver. It is freely filtered 
by the glomerulus and passively reabsorbed in tubules. Hence it 
underestimates GFR. In cases of reduced renal perfusion due to volume 
depletion or anti-diuresis  urea absorption is further increased thereby 
lowering GFR further. Urea generation is increased in cases of catabolic 
states like infection, chemotherapy, hyper-alimentation or GI bleed. Urea 
generation is decreased in liver disease and severe malnutrition. 
CYSTATIN–C: 
Cystatin-c is a protein with a molecular mass of 13kd. It  has  
following  
functions
[17] 
-inhibiton of cysteine protease 
-anti-bacteial and anti-viral action 
-immuno modulatory effects 
-modulation of body response to brain injury. 
Cystatin-C is produced by all nucleated cells at a constant rate. It is freely 
filtered, and 99% is reabsorbed and catabolised only 1% remaining is 
excreted though some element of tubular secretion  and extra renal 
elimination is also found out in some studies
[17],[18].
 
Cystatin –C levels were found to be high (after correcting for 
measured GFR)  due to following factors: male sex, old age, whites, 
obesity, hypoalbuminemia and diabetes 
[21],[22] 
Assays for cystatin-C are expensive . Two methods used are: 
1) particle enhanced turbidimetric assays 
2) particle enhanced nephelometric assays 
Cystatin –C levels in serum predicts GFR better than creatinine but 
equations in based on cystatin –C are not considered better than creatinine 
based equations. In cases of acute kidney injury serum cystatin –C was 
found to be an earlier when compared to creatinine
[19].
There are some 
studies which show that equations employing both creatinine and cystatin-
C are better predictors of GFR
[20],[25].
 Cystatin –C was found to be better 
marker in diabetic patients when compared to creatinine 
[26] 
 
DTPA RENAL SCAN: 
The  nuclear medicine renal scan is commonly  performed by using  
DTPA  
(Diethylene triamine penta acetic acid) radio labeled with  Technetium 99. 
Its clinical implications are to evaluate: 
1)  the blood supply of the kidneys  
2) the function and excretion of urine from the kidneys 
3) split GFR of each kidneys 
4) renal tubular function and perfusion 
5) reno-vascular hypertension  
6) renal artery stenosis 
7) renal tubular obstruction and trauma or damage 
8) blockage or interruption of the ureters 
9) renal transplant perfusion and function 
          PREPARATION OF THE PATIENT: 
First of all the patient has to be hydrated adequately. In case 
of reno-vascular hypertension or suspected renal artery stenosis, 
anti-hypertensives have to be stopped 4-7 days prior to the 
examination. In case of pregnancy and breast feeding precautions 
has to be taken to stop breast feeding and minimize non- essential 
contact with the baby for a short period of  time . 
For the DTPA renal scan patient has to lie supine on the 
scanning bed, with the gamma camera under the bed. The patient 
should not move during scanning as it will blur the images and give 
poor scan results. An IV cannula is placed, radiolabelled DTPA is 
injected and this can be detected by the gamma camera . 
After 15 minutes of scanning IV frusemide injection is given, this 
helps by 
1) Increasing the amount of urine that the kidney makes, by 
decreasing amount of water that the kidney reabsorbs. 
2) Increasing flow of urine in the tubules and the ureter thereby 
enabling tubular details. 
After 30 minutes of scanning ask the patient to void urine, once the 
bladder is emptied, scanning is continued for further 2 minutes, and a 
repeat scanning is done at 4 hours. The IV cannula is removed  after the 
procedure .There are no after effects of a DTPA renal scan. 
IMPLICATIONS OF ESTIMATED GFR: 
IN CHRONIC KIDNEY DISEASE-  
Recent guidelines states early detection of CKD by monitoring for 
albuminuria or measuring GFR, and serum creatinine is a poor 
marker for early CKD. Our estimating equations based on creatinine 
are found to be less accurate when due to multiple factors affecting 
measured creatinine values. Hence exogenous filtration markers or 
timed urine collection for creatinine clearance are to be employed in 
future  
IN ACUTE KIDNEY INJURY- 
 
     AKI is a non–steady state. The endogenous  filtration markers 
requires time for retention before their levels raise in blood. During 
recovery from an AKI, even after normalization of GFR, the 
filtration markers may take time for their clearance. Hence estimated 
GFR values may not reflect the actual measured. In those cases only 
a change in estimated GFR may reflect the magnitude and direction 
of the change in measured GFR.        
     
   CHRONIC KIDNEY DISEASE (CKD) 
DEFINITION: 
CKD is defined as  
1) Kidney damage for 3 months or longer, as defined by structural or 
functional abnormalities of the kidney, with or without decreased 
glomerular filtration rate (GFR), manifesting by either : 
A) Pathological abnormalities  
B) Markers of kidney damage, including abnormalities in 
the composition of the blood or urine, or abnormalities in 
imaging 
2) GFR of less than 60 ml/min per 1.73m2 for more than 3 months with 
or without kidney damage. 
 In other words CKD is defined by the presence of sustained 
abnormalities of the  renal  function  and  results  from  various  
causes  of renal  injury. CKD can lead to progressive loss of renal 
function, and may terminate in ESRD after a variable period of time 
following the initiation injury. There has been lot of changes in the 
collective view of CKD. The terms chronic renal insufficiency, 
chronic renal failure, chronic renal disease have all been replaced by 
the single  term  chronic kidney disease 
 
STAGES OF CKD: 
NKF-K/DOQI
[2]
 CKD  staging 
   STAGE             DESCRIPTION GFR,ml/min/1.73m
2
 
       - At increased risk >60 with CKD 
risk factors 
      1 Kidney damage with normal 
or increased GFR 
         >90 
      2 Kidney damage with slightly 
decresased  GFR 
          60-89 
 
      3 Moderately decreased GFR            30-59 
      4 Severely decreased GFR           15-29 
      5 Kidney failure            <15 
 
 The risk factors for CKD include hypertension, diabetes mellitus, 
autoimmune disease, older age, African ancestry, family history of 
renal disease, a previous episode of acute renal failure, abnormal 
urinary sediment, structural abnormalities of the urinary tract. and 
the presence of proteinuria (micro-albuminuria or overt proteinuria) 
 
STAGING RENAL INVOLVEMENT BASED ON 
PROTEINURIA 
 
Stage Urine dipstick test 
for protein 
24hr urine albumin  
Normal Negative < 30mg/day 
Microalbuminuria Negative 30-300 mg/day 
Macroalbuminuria 
(overt proteinuria) 
Positive >300 mg/day 
 
PATHOPHYSIOLOGY  OF CKD: 
Two sets of mechanisms operate, to produce renal disease  
1) Initiation of renal injury by immune complexes, chemical 
mediators of inflammation or toxins. 
2) Progression of renal injury by mechanisms like hyperfiltration 
and hypertrophy of the remaining nephrons. 
Glomerular hyper filtration can maintain GFR initially, but later can 
lead to glomerular injury. Abnormal glomerular permeability can 
initiate proteinuria thereby aggravates glomerular injury. There are 
also evidences to suggest that proteinuria can cause tubulointerstitial 
disease. The extent of tubulointestitial damage determines renal 
disease progression in all forms of glomerular disease. 
 
RISK FACTORS FOR PROGRESSION OF CKD 
1) Ethnicity is a risk factor for many renal diseases. African 
American diabetics have three fold higher risk of developing 
ESRD. They also develop HIV-associated nephropathy more 
frequently than the rest. 
2) Gender is an additional risk factor for renal disease progression 
as the overall incidence of ESRD is greater in males than in  
females . 
3) Smoking is associated with kidney disease progression in 
diabetes, IgA nephropathy, lupus nephritis, and polycystic kidney 
disease 
4) Increased consumption of non narcotic analgesics has been 
associated with increased risk of CKD.  
MEASURES TO RETARD PROGRESSION OF RENAL DISEASE : 
Optimal control of BP is very important to retard the progression of 
renal disease. The joint national committee (JNC) -7 recommends BP 
reduction to below 130/80mm Hg in case of diabetics and CKD patients. 
Inhibition of the Renin-Angiotensin  and Aldosterone system by  
Angiotensin converting enzyme (ACE) inhibitors and Angiotensin receptor 
blockers has renoprotective effects [RENAALSTUDY, IDNT STUDY, 
UKPDS STUDY, HOPE STUDY, REIN STUDY] 
 
RENAL REPLACEMENT THERAPY (RRT): 
It is defined as life supporting measures employed for renal failure. It 
includes: 
1) Hemodialysis  
2) Peritoneal dialysis 
3) Hemofiltration 
4) Renal transplantation     
 
 
CRITERIA FOR RRT: 
 Creatinine clearance of <10ml/min/1.73m2 
 Hyperkalemia refractory to medical measures 
 Volume over load status  
 Metabolic acidosis refractory to medical measures  
 Bleeding diathesis 
HEMODIALYSIS: 
The principle behind hemodialysis is diffusion of solutes across 
semi-permeable membrane. The dialysate flows opposite to blood flow 
direction in extra corporeal circuit, this counter-current flow maintains 
concentration gradient increasing efficacy of dialysis. Hemodialysis 
removes urea, potassium and free water from the blood.  
HEMOFILTRATION: 
It requires a semi-permeable membrane, and the dynamics are governed 
by convection rather than diffusion. Dialysate is not used here , hence a 
positive hydrostatic pressure is needed for driving water and solutes to 
filtrate compartment. This drags both small and large solute particles.This 
procedure causes less hemodynamic instability when compared to 
hemodialysis but,  this is an expensive option. 
 
PERITONEAL DIALYSIS: 
Here the peritoneal membrane acts as semi-permeable membrane and the 
dialysis fluid is instilled in the peritoneal cavity. The solutes are removed 
by diffusion and excess fluid is removed by osmosis. This is a simple 
procedure and effective both in children and elderly 
Types of peritoneal dialysis : 
 Continuous ambulatory peritoneal dialysis 
 Automated peritoneal dialysis 
 Intermittent peritoneal dialysis 
 Night intermittent peritoneal dialysis 
 Tidal intermittent dialysis  
 RENAL TRANSPLANTATION: 
     It is the procedure of transplantation of kidney in a patient having end 
stage renal failure. Patient can gain a life expectancy of 10-15 years 
excess, when compared to patients placed of dialysis. Transplantation 
should be opted as soon as the ESRD is diagnosed, as patients placed on 
dialysis for longer duration before transplantation are found to have lesser 
survival, when compared to the earlier transplantation group.  
 
 
PATIENT SELECTION  
Age is usually <70 years, although patients older than 75 years showed 
better life  expectancy after transplantation when compared to dialysis.      
Patients should not receive transplant in following situations- 
1) Active infection 
2) Ongoing active immunologic disease 
3) Metastatic malignancy 
4) Inability to follow drug regimen due to mental illness or any 
substance abuse  
HIV infection was historically a contraindication to transplantation, but 
successful kidney transplantation  is possible if they have a CD4 count of 
>200 cells/cumm, they are  free from opportunistic infections and have 
negligible viral load. 
 
INDICATIONS FOR RENAL TRANSPLANTATION: 
1) End stage renal disease 
2) Glomerulo nephritis 
3) Polycystic kidney disease 
4) Autoimmune conditions SLE 
5) Malignant  hypertension  
 CONTRAINDICATIONS FOR RENAL TRANSPLANTATION: 
1) Malignancy 
2) Liver disease 
3) Cardio-pulmonary insufficiency  
4) Substance abuse and mental illness 
Smoking and obesity are associated with increased peri-operative 
complications.  
COMBINED KIDNEY AND PANCREAS TRANSPLANTATION: 
 This procedure is being tried in type-1 diabetics with diabetic 
nephropathy. It may be of two types 
1) Combined kidney and pancreas transplant 
2) Pancreas after kidney transplant  
     COMPLICATIONS OF RENAL TRANSPLANTATION:  
1) Transplant rejection  
2) Infection and sepsis due to immune suppressants 
3) Post transplant lympho-proliferative disorders 
4) Electrolyte imbalances 
5) Acne, hirsutism, hair loss, obesity, dyslipedemia, diabetes.  
 
 
FUTURISTIC APPROACH TO CKD: 
The Renal Physician’s association and The National Kidney Disease 
Education program, proposed several CKD clinical guidelines .These 
address bone disease, hypertension, nutrition, and cardiovascular disease. 
Most recently, two significant changes have occurred. First, there is a big 
push to make guidelines in CKD as a global perspective. Second, there is 
tremendous enthusiasm to raise the awareness of CKD as a public health 
problem both in the developed world and in the developing world. 
Despite all these progresses, much remains to be done. Although 
strategies to slow progression are available, such as angiotensin blockade 
and a more aggressive target for blood pressure reduction, many  patients  
still  progress to end stage renal disease. Understanding the role of genetic 
factors in disease progression and in disease treatment(pharmacogenomics) 
remains an embryonic field as it pertains to the CKD care . 
The role of much investigated measures, such as dietary protein 
restriction remains unresolved .Although the toll that cardiovascular 
disease (CVD) has taken and continues to take, in terms of morbidity and 
mortality in CKD patients is obvious and staggering, the precise role of 
factors that account for this heightened risk of CVD remains unclear. 
Preventing CVD in CKD patients continues to be an important challenge . 
The mechanistic aspects of the complications of CKD  (eg. 
Abnormalities in mineral metabolism and anaemia) have not been 
completely resolved ;nor for that matter have all aspects of treatment. For 
example the optimal hemoglobin target in a CKD patient remains a 
conjecture. The management of bone and mineral metabolism continues to 
be challenging. To try and improve CKD management and implement 
guidelines in CKD  patients, the concept of CKD CLINIC  has emerged. 
The CKD CLINIC is a multi-disciplinary clinic led by a physician or 
a nurse that focuses on all aspects of CKD care, running the gamut from 
renal progression management to the treatment of complications. Although 
many centres are now setting up CKD CLINICS, the precise structure of 
these clinics, the target population, and the relationship between the CKD 
CLINIC  and  referring doctors has not been worked out. It is hoped that 
the next decade will herald new data and better evidence will allow us to 
tackle CKD care as a global issue.  
         
 
 
 
 
 
MATERIALS AND METHODS 
STUDY DESIGN          : observational study 
STUDY PLACE            : Department of  Nephrology 
                                         Government Stanley Hospital 
                                         Chennai-1 
STUDY PERIOD           :  6 months  ( april 2011-september 2011) 
STUDY POPULATION: Individuals attending Nephrology OPD  for             
                                          undergoing evaluation for kidney      
                                           transplantation 
SAMLE SIZE                  : 50 individuals 
SAMPLING                     : Simple random sampling 
INCLUSION CRITERIA: 
                       Normal individuals who are willing for kidney donation and   
undergoing evaluation for the same.  
 
 
EXCLUSION CRITERIA: 
1)Age <20 and > 55 years 
2)ABO incompatibility 
3)Donors with h/o HT,DM 
4) Donors with newly detected HT,DM 
5)Females with h/o gestational diabetes and gestational hypertension 
6)Donors with family h/o renal disease 
 
      After getting approval from the institutional ethical committee the 
study was started, All the individuals were given information form and 
consent form. After signing the informed consent form they were enrolled 
into the study. 
                   HOW THE STUDY WAS CONDUCTED: 
        Individuals who were willing for kidney donation for their relatives 
and friends were included . They were maintained on a regular diet, and 
were  subjected to  thorough history, clinical  examination, biochemical  
investigations, screening  ultrasonogram of the abdomen and finally DTPA 
renal scan.  
 Assessment panel includes- 
 Measurement of body weight in kg 
 Blood pressure 
 Biochemical investigations: 
- Urine : albumin,sugar,deposits 
- Hemoglobin 
- Blood grouping and typing 
- Bleeding time and clotting time 
- Random blood sugar 
- Blood urea nitrogen 
- Serum creatinine 
 Screening  ultrasonogram of the abdomen 
   Results were duely collected and analysed.  
Glomerular filtration rate was calculated by the following methods. 
Downloadable calculators were used for calculation.These calculators 
requires only the variables to be substituted. 
 
COCKCROFT-GAULT FORMULA: 
                              eGFR=
                       
                      
                  
 MDRD FORMULA FOR e GFR : 
                                                    
                             
 
 
CKD-EPI FORMULA FOR e GFR: 
 141 x min (SCr/k,1)a x max(SCr/k,1)-1.209  x 0.993age x [1.018 if female] x  [1.159 if 
black] 
 
where SCr is serum creatinine (mg/dL), k is 0.7 for females and 0.9 for 
males, a 
 is -0.329 for females and -0.411 for males, min indicates the minimum 
of  
 SCr/k or 1, and max indicates the maximum of SCr/k or 1. 
 
Then they  were  subjected to the DTPA RENAL SCAN: 
Preparation for DTPA SCAN :  
They were given 1 litre of water to drink one hour before the 
procedure, patient was called again and Tc 99 labelled DTPA injection was 
given intravenously. Then the  patient was made to lie in supine position 
on the table where the film was being  taken from above. After injection of 
the dye film was taken from zero minute to  upto 30 minute. IV injection 
frusemide 20mg was given at 15
th
 minute. After that patient was asked to 
void urine and immediately a post void film was taken.  Four hours later 
another film was taken. 
No adverse reactions were observed during and after the procedure. 
Now the results were analysed, how closely the estimated values correlate 
with that of the DTPA renal scan.  
Correlation was made by calculating pearson co-relation coefficient,  
Student `t` test was used for comparison.`R` statistics were obtained by 
simple linear regression. This reflects the predictive ability of the model. p-
value of 0.05 was considered statistically significant. The Bland and 
Altman method was used to determine concordance between DTPA scan 
with the prediction equations. 
 
 
 
 
 
 
RESULTS 
This study included 50 individuals who underwent renal donor workup at 
the Department of Nephrology, Government Stanley Hospital. Their GFR 
was calculated  by 3 different  methods  namely  COCKCROFT-GAULT 
formula, MDRD formula and CKI-EPI formula and they were compared 
with the  DTPA renal scan reports. The results were tabulated and analysed 
as follows : 
Table 1 . AGE DISTRIBUTION 
AGE GROUP (years) NUMBER PERCENTAGE 
<30 7 14 
31-40 11 22 
41-50 19 38 
>51 13 26 
 
Table 2 .SEX DISTRIBUTION 
SEX NUMBER 
Male 12 
Female 38 
Table 3 . SEX  AND  AGE  GROUP DISTRIBUTION 
AGE 
GROUP 
(years) 
MALES FEMALES 
NO. % NO. % 
<30 1 2 6 12 
31-40 4 8 7 14 
41-50 3 6 16 32 
>51 4 8 9 18 
 
PARAMETERS TOTAL MALES FEMALES 
MEAN 43.4 43 43 
MEDIAN 45 45 45 
STD.DEVIATION 9.5 10 9 
RANGE 31 26 31 
 
Thus it is evident majority of our study group belongs to the age group of 
41-50 years and almost three forth of our study group comprises of 
females.  
  
Chart 1 . AGE DISTRIBUTION: 
 
 
 
 
Chart 2 .SEX DISTRIBUTION: 
 
 
 
 
 
 
 
  
  Table 4 .BASELINE CLINICAL AND LABORATORY PROFILE 
PARAMETE
S 
MEAN MEDIA
N 
STD SE OF 
MEAN 
RANGE 
AGE 43.42 45 9.35 1.32 31 
BODY. 
WT(kg) 
58.66 59 5.24 0.74 22 
24 hr UP 133.18 132.50 27.39 3.87 95 
Hb gms% 10.8 10.85 1.18 0.17 4.6 
RBS mg/dl 123.62 121.0 26.22 3.71 95 
BUN 10.84 9.6 3.72 0.53 18.8 
S.CREATINI
NE 
1.01 1.0 0.18 0.03 0.8 
S.ALBUMIN 4.1 4.1 0.23 0.03 1.1 
 
 
Table 5 :DISTRIBUTION OF GFR (DTPA) IN VARIOUS AGE 
GROUPS: 
AGE 
GROUP(years) 
SEX GFR BY DTPA SCAN 
MEAN MEDIAN SD RANGE 
 
>30 
Male 107 107 - - 
Female 99.8 101.5 7.9 21 
31-40 Male 111.5 110 5.7 12 
Female 97.8 94 13.4 32.5 
41-50 Male 105.7 105 13 26 
Female 98.8 99 12.5 41.8 
>50 Male 98.6 100 14.2 31.6 
Female 91.9 92 9 27.6 
 
This table shows that the mean GFR calculated by DTPA scan of  is higher 
in the males than the females and mean GFR is maximum in the age group 
of 31-40 years and mean GFR decreases as age advances  
 
 
 
 
Chart 3 . MEAN GFR  AND  AGE GROUP ANALYSIS 
 
 
 
 
 
 
Chart 4 . MEAN GFR AND SEX DISTRIBUTION ANALYSIS 
 
 
 
 
 
  
 GFR is calculated by downloadable calculators for the respective equations 
and their mean,  median, standard deviation and standard error of mean are 
tabulated    
Table 6 .GFR BY  VARIOUS  METHODS 
 
METHOD MEAN MEDIAN STD. 
DEVIATION 
STD. 
ERROR 
OF MEAN 
C-G 71.23 67.11 16.75 2.37 
MDRD 71.82 69.63 16.75 2.37 
CKD-EPI 76.50 73.50 17.84 2.5 
DTPA SCAN 99.12 99.47 11.73 1.66 
[C-G-cockcroft-gault] 
 
Thus it is inferred from the above that the mean GFR calculated by DTPA 
> CKD-EPI > MDRD > C-G. The standard error of  mean is 2.37, 2.37, 
2.5, 1.66 for Cockcroft-Gault, MDRD, CKD-EPI  equations and DTPA 
scan respectively.   
Chart 5 : MEAN GFR BY VARIOUS METHODS 
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 Table 7 .COMPARISON OF DIFFERENCE IN GFR FROM DTPA 
SCAN: 
 
METHOD 
MEAN 
GFR 
MEAN 
DIF 
DTPA 
MEDIAN 
DIF. 
DTPA 
STD 
DIF. 
DTPA 
MEAN% 
DIF. 
DTPA 
C-G 71.23 27.88 28.95 17.93 27.65 
MDRD 71.82 27.30 28.45 17.27 27.17 
CKD-EPI 76.50 22.62 23.5 18.09 22.42 
 
 After calculating the mean GFR, their difference from the DTPA scan was 
calculated. The difference in GFR was much lesser in case of CKD-EPI 
formula when compared to MDRD and COCKCROFT-GAULT. The 
median difference from DTPA and the mean percentage difference were 
lesser with CKD-EPI formula.   
Thus it is seen that the prediction equations, Cockcroft-gault, MDRD and 
CKD-EPI underestimated GFR by 27.65%, 27.17% and 22.42% when 
compared to DTPA renal scan 
 
 
Table 8 . ACCURACY OF COCKCROFT-GAULT FORMULA: 
% OF ERROR NO. OF PATIENTS % OF THE STUDY 
GROUP 
<25 20 40 
25-40 17 34 
>40 13 26 
 
Thus COCKCROFT-GAULT formula predicts GFR with  < 25% error in 
almost 40% of patients,25-40% error in 34% of patients and >40% error in 
26% of patients.  
Table 9 .ACCURACY OF THE MDRD FORMULA: 
% OF ERROR NO OF PATIENTS % OF THE STUDY 
GROUP 
<25% 22 44 
25-40% 18 36 
>40% 10 20 
Thus MDRD formula predicts GFR with <25% error in 44% of patients, 
25-40% error in 36% of patients and >40 % error in 20% of patients. 
 
Table 10 :ACCURACY OF CKD-EPI FORMULA: 
% OF ERROR NO OF PATIENTS % OF THE STUDY 
GROUP 
<25 25 50 
25-40 18 36 
>40 7 14 
 
Thus CKD-EPI formula predicts GFR with <25% error in 50% of patients, 
25-40% error  in 36% of patients and >40% error in 14% of patients.  
 
 
 
 
Chart 6 : ACCURACY  OF COCKCROFT –GAULT FORMULA 
 
 
 
 
 
 
 
 
Chart 7 : ACCURACY OF MDRD FORMULA 
 
 
 
 
 
 
 
 
Chart 8 : ACCURACY OF CKD – EPI  FORMULA 
 
 
 
 
 
  
  
Table 12 : CORRELATION OF COCKCROFT-GAULT WITH 
DTPA SCAN 
Pearsons coefficient ‘r’ 0.246 
Linear regression R
2
 0.061 
Significance2-tailed, 
[pvalue] 
0.085 
 
P –value of  <0.05 was considered statistically significant , it is evident 
that there is a correlation  between Cockcroft-Gault  equation and DTPA  
but that is not a statistically significant correlation 
 
 
 
 
 
 
Chart 9 : LINEAR REGRESSION  PLOT OF DTPA AND CG 
 
 
 
 
 
 
  
Table 13 : CORRELATION OF MDRD WITH DTPA SCAN: 
 
Pearsons  Coefficient, ‘r’ 0.305 
Linear regression R
2 
0.093 
Significance -2 tailed 
[P value] 
0.031 
 
 
P- value of <0.05 was considered statistically significant and it is evident 
that there is a statistically significant  correlation between MDRD equation  
and DTPA scan. 
 
 
 
 
 
 
Chart 10 : LINEAR REGRESSION  PLOT OF MDRD AND DTPA  
 
 
 
  
Table 14 :CORRELATION OF CKD-EPI WITH DTPA: 
Pearsons coefficient, ‘r’ 0.307 
Linear regression R
2 
0.094 
Significance 2-tailed 
[P value] 
0.03 
 
 
P-value of <0.05 was considered as statistically significant, again there is a 
statistically significant correlation between CKD-EPI equation  and  DTPA 
scan 
 
 
 
 
 
 
Chart 11 : LINEAR REGRESSION PLOT OF CKD-EPI AND DTPA 
 
 
 
 
 
 
  
Table 15 : COMPARISON OF CO-EFFICIENT OF CORRELATION 
FORMULA COEFFICIENT 
OF 
CORRELATION 
P-VALUE SIGNIFICANCE 
Cockcroft-
Gault 
0.246 0.085 Not significant 
MDRD 0.305 0.031 Significant 
CKD-EPI 0.307 0.030 Significant 
 
Our study aims to compare three different methods (Cockcroft-
Gault,MDRD, and CKD-EPI equations)  with the  gold standard method 
(DTPA scan), hence we apply  Bland and Altman method to establish the 
concordance between them.  
 
 
 
 
 
 
 
Chart 12 :BLAND & ALTMAN PLOT FOR  C-G AND DTPA SCAN 
 
 
 
 
 
 
 
 
Chart 13 : BLAND & ALTMAN PLOT FOR    MDRD AND DTPA 
SCAN 
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Chart 14  : BLAND & ALTMAN PLOT FOR  CKD – EPI AND 
DTPA SCAN 
 
 
 
 
 
 
 
 
 TABLE 15 : CONCORDANCE ANALYSIS OF C-G , MDRD,& 
CKD-EPI 
COMPARISON  
WITH DTPA 
  CONCORDANCE    
      INTERVAL 
CONFIDENCE 
 
  INTER VAL 
  MEAN  
 
DIFFERENCE  
 
  IN GFR 
UPPER 
LIMIT 
LOWER 
LIMIT 
COCKCROFT  
 
   GAULT 
 
7.3 
 
-63 
 
95% 
 
27.9 
    
   MDRD 
 
6.5 
 
-61.1 
 
95% 
 
27.3 
 
  CKD-EPI 
 
12.8 
 
-58.1 
 
95% 
 
22.6 
 
It is obvious that majority of the plots are clustered around the mean line 
with a confidence interval of 95%, however these equations tend to 
underestimate GFR  at all the levels with a mean difference of 27.9ml/min, 
27.3ml/min and 22.6ml/min  for Cockcroft-Gault, MDRD, and CKD-EPI 
respectivel 
 
DISCUSSION 
Chronic kidney disease is a global (CKD) problem, gaining 
importance day by  day. CKD burden increases due to 
-increased prevalence of   hypertension, diabetes and cardiovascular   
 diseases 
-better availability of  the  treatment   
-decrease in mortality and morbidity 
There are studies, which show that  the prevalence of early CKD is 
much greater than the prevalence of late CKD 
[27].
 Hence early detection of 
CKD and initiation of treatment measures to halt its progression is the need 
of the hour. 
The concept of using serum creatinine as a marker of GFR is not 
validated in most of  the clinical settings .Since a 50 % fall in GFR is 
necessary  for the creatinine level to rise, it is high likely that early cases of 
CKD may be  missed. GFR can be estimated using prediction equations, 
again these equations employing serum creatinine depends on the 
calibration and variability of the method used
[28].
However the new 
K/DOQI guidelines recommend use of prediction equations in estimating 
GFR 
[2].
 
Our study, an observational study involving 50 prospective renal 
donors employed various prediction equations (Cockcroft-gault, MDRD, 
CKD-EPI) to estimate GFR and compared their values with DTPA renal 
scan.  
The mean GFR estimated by Cockcroft-gault, MDRD and CKD-EPI 
formula were 71.23, 71.82 and 76.50; likewise the mean difference from 
DTPA scan were 27.86, 27.30 and 22.62 respectively. Thus it is obvious 
the prediction equations significantly underestimates the GFR. However 
there was a fair amount of correlation of these prediction equations with 
the DTPA scan values, where CKD-EPI correlating better among the three  
.Cockcroft-Gault  formula does not correct for race of the 
individuals,  also our study group comprised of  predominantly of  elderly 
females. The serum creatinine not being calibrated with standard 
measurements, could be another reason for underperformance of the 
Cockcroft-Gault . 
MDRD  formula was devised , based on the creatinine clearance of 
the CKD population. Our study group being normal individuals, might 
contribute for underperformance of  the MDRD. There were studies where 
MDRD underestimated GFR  upto 29% 
[ 29].
Again errors in caliberating 
serum creatinine might be a potential reason for underperformance of the 
MDRD
[30].
 
Regarding the CKD-EPI formula , it was introduced recently and 
was not validated in different clinical studies. Although limited references 
states that CKD-EPI performs better than MDRD 
[16],[23]. 
In our study CKD-
EPI also underestimates GFR, with a mean of 76.50 ml/min where mean 
GFR measured by DTPA was 99.12 ml/min. The possible causes could be 
the predominant study population being elderly females, none of them 
being African-American, and errors in serum creatinine estimation. It 
requires creatinine estimation by isotope dilution mass spectrometry, 
which again could be a setback  in our study. 
There were many studies reported in the literature , comparing  the 
predicting equations namely Cockcroft-Gault and MDRD. In the Levey et 
al study 
[ 31]
 ,1628 CKD patients where included and the mean GFR was 
48.6. The creatinine clearance estimated by 24 hour urine creatinine 
clearance and the Cockcroft-Gault overestimated GFR BY 16% but 
MDRD performed better in them.In the Lewis et al 
[32]
 study 1703  African 
–American patients with CKD were included, where the mean GFR was 
56.8. Here Cockcroft-Gault underestimated GFR and MDRD estimated 
GFR accurately, the study population being the CKD patients MDRD 
performed better in these studies .In Bertolus  et al study 
[33]
, 22 potential 
donors with creatinine clearance <80ml/min were  included, and showed 
both the equations performed poorly and it suggested to index serum 
creatinine by height rather than body surface area . 
In the Bostom et al study 
[34],
109 CKD patients were included ,  
showed MDRD was a much precise equation , but considering the multiple 
possibilities of error the equation  has to be used with caution. 
Measurement of GFR using markers like Inulin, DTPA,  Iohexol and  
Iothalamate being cumbersome MDRD may be used to estimate GFR in 
patients with early CKD. 
In  the Vervootet al 
[35]
 study, 46 healthy adults and 46 type 1 
diabetics without proteinuria were included and showed that the MDRD 
equation performed poorly in the diabetics. In the Kingdon et al 
[36]
 study, 
26 patients with scleroderma were included and they found that the MDRD 
equation employing demographic and serum variables performed  
excellently in those patients .In the Poggio et al study 
[40]
, MDRD equation 
overestimated GFR in CKD patients and both MDRD and Cockcroft-Gault 
equations underestimated GFR in patients with normal kidney function. In 
the Rule et al study
[42]
, as a result of sub optimal accuracy of the prediction 
equations they cannot be generalized and new prediction equations based 
on markers like cystatin-C needs to be devised. They are not reliable in 
potential kidney donors.  
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 Although all  these studies have employed Cockcroft-gault and 
MDRD equations none employed CKD-EPI. Only few studies were 
reported , which employs CKD-EPI equation.   A research article from 
France
[37]
 , states that prediction equations   (MDRD, CKD-EPI)  created 
discrepancy in epidemiological assessment of CKD prevalence. 
A study in Australia in 2010 
[38]
 showed , the prevalence of CKD in 
the Australian population aged  more than 25 years, using MDRD  was 
13.4% , the prevalence was 11.5%  using CKD-EPI , this was because 266 
individuals in the study  who belonged to the CKD group, according to 
MDRD equation were reclassified as not having CKD by the CKD-EPI , 
due to better estimation of GFR . 
Another study in Netherlands 
[39]
 , stated that both MDRD and 
CKD-EPI  were able to predict with higher accuracy when compared to 
other equations .Lin et al study
[41]
,  the MDRD equation  underestimates 
GFR, and  the Cockcroft-Gault equation  consistently overestimates 
measured GFR in people with normal kidney  function. In potential kidney 
donors, prediction equations may not be sufficient for estimating GFR and 
radioisotope studies like DTPA SCAN  may be needed for a better 
assessment of GFR.  
 In a Chinese study of comparing the prediction equations in 
potential live kidney donors 
[43]
 all the prediction equations performed 
poorly and considering the importance of the kidney transplantation more 
accurate methods of GFR calculation needs to be devised . 
Another study from Thailand 
[44]
 included  60 healthy adults, and 
found that the prediction equations were suboptimal, and suggested newer  
methods for employing prediction equations among various ethnic groups. 
Winding up, in our study on 50 potential donors, the prediction 
equations namely Cockcroft-gault, MDRD and CKD-EPI underestimated 
GFR by 27.65%, 27.17% and 22.42%  respectively  when compared to 
DTPA  renal scan.These equations were able to predict GFR with <25% 
error in 40%, 44% and 50% of the study group for Cockcroft-Gault , 
MDRD, and CKD-EPI  respectively. 
However  all these 3 equations were found to correlate with DTPA 
scan values, the correlation was statistically significant for MDRD and 
CKD-EPI, and statistically not significant for Cockcroft-Gault equation 
.Hence it is inferred that these prediction equations cannot be solely 
relied upon in case of  clinical settings like renal transplantation and so 
further research is required for devising newer methods which could be 
applicable in all the clinical settings, all age groups, both sexes, and all 
ethnic groups !!  
LIMITATIONS OF THE STUDY: 
- very small sample size  
- African Americans were not included in the study 
- study group  predominantly comprises of  females 
- the values were not calibrated with standard  measurements 
- the source of error could possibly  be intra-individual variability in 
serum creatinine, laboratory methods, GFR per se and GFR 
measurement   
 
 
 
 
 
 
 
 
                         SUMMARY AND CONCLUSIONS: 
 The prediction equations namely  Cockcroft-Gault, MDRD and  
CKD-EPI were found to correlate with the DTPA scan values.   
 However they underestimated GFR by 27.65%, 27.17%  and  
22.42% respectively,  the possible reasons could be  
             -lack of standardization in calibration of serum creatinine 
            -study population predominantly being females  
            -sample size was small  
            -African –Americans were not  included in the study 
            -MDRD and Cockcroft-Gault were  devised in the CKD 
setting and not  in the normal population , our study group belonged to 
normal and healthy        adults. 
 These prediction equations were not validated in our population and 
our clinical set up. 
 DTPA scan  gives split GFR of each kidney, renal tubular function, 
details about renal blood supply, renal tubular obstruction or 
damage 
 DTPA scan cannot be substituted by the prediction equations  in 
special situations like renal transplantation  
 However extensive research work are under process , which may 
bring  out newer, more accurate, less invasive and cheaper ways of  
estimating GFR which can be applicable in all the clinical settings. 
 Let us hope we achieve that in the near future.  
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PROFORMA  
Serial number : 
Date : 
Name : 
Age : 
Sex : 
Address : 
 
Contact phone number : 
Occupation : 
Relation to the patient : 
Body weight in kg : 
History of diabetes /hypertension : 
Family history of renal disease : 
Pulse :                                                                          Blood pressure : 
Cardiovascular system : 
Respiratory system : 
Urine : albumin, sugar, deposits 
24 hour urine protein : 
Hemoglobin : 
Bleeding time :                        
Clotting time : 
Random blood sugar : 
Blood urea nitrogen (mg/dl) : 
Serum creatinine (mg/dl) : 
Serum albumin (g/dl) : 
Ultrasonogram abdomen : 
DTPA renal scan report :  
 
 
 
 
S.N. NAME AGE SEX RELATION 
 
WT.KG  HT/DM F. H/O.R. D BP 
24 Hr 
UP Bl.G Hb BT  CT  RBS BUN S.Cr ALB USG C-G MDRD CKD-EPI DTPA  
1 sakunthala 52 F mother 60 no no 130/80 180 B 10.5 2 5 140 8.4 0.8 3.9 N 77.93 80.06 85 93 
2 gandhimathi 50 F mother 57  no no 124/76 140 O 9.3 1 4 135 7.9 0.8 4 N 75.7 80.07 86 97 
3 jeyanthi 41 F sister 52 no no 110/70 110 A 11 2 4 124 7.9 0.9 4.5 N 67.53 73.34 80 116 
4 Jothi 26 F sister 64 no no 120/76 160 B 11.8 1 6 150 7.4 0.8 4.2 N 107.67 92.2 101 106 
5 sardhani 35 F sister 49 no no 110/70 120 O 9.8 2 6 160 14.4 1 4.4 N 60.74 67.06 73 106 
6 kalaiselvi 50 F mother 66 no no 138/80 135 B 10.9 2 4 110 7.9 0.9 3.9 N 77.92 70.44 75 108 
7 ramakrishnan 33 M brother 63 no no 120/84 115 AB 12 1 3 130 9.4 0.9 4.1 N 104.03 109.21 112 107 
8 kuppammal 42 F mother 57 no no 116/76 100 B 10 2 5 108 7.4 0.7 3.9 N 94.2 97.5 107 97 
9 muniammal 48 F mother 61 no no 130/80 137 O 8.9 1 4 97 19.8 1.4 4.1 N 47.32 42.66 44 107.9 
10 kanniammal 28 F daughter 49 no no 108/76 123 B 9.7 3 6 117 8.9 0.8 4.3 N 80.99 90.78 101 97 
11 shantha 50 F mother 59 no no 130/80 165 B 11.4 2 3 141 14.9 1.2 4 N 52.24 50.54 53 108 
12 Malar 40 F mother 67 no no 124/80 115 A 10.9 1 4 109 8.9 0.9 4.8 N 87.89 73.71 80 94 
13 Mallika 55 F mother 58 no no 136/84 140 B 9 2 6 145 8.4 0.9 4.4 N 64.67 69.09 72 92 
14 anushya devi 48 F  sister 51 no no 126/80 155 A 11 1 5 118 7.9 0.8 4.1 N 69.24 81.37 87 83.05 
15 sulthan basha 32 M brother 60 no no 130/76 110 B 13 2 4 157 13.9 1 4.5 N 90 92.04 99 107 
16 Pattu 54 F mother 55 no no 140/80 165 O 10.7 3 5 132 11.9 1 4 N 55.8 61.4 64 108 
17 bhuvaneshvari 29 F sister 55 no no 110/72 95 O 9.8 1 4 155 19.3 1.5 4.1 N 48.05 43.64 47 86 
18 Ponni 30 F sister 48 no no 126/80 140 AB 11 2 5 110 20.8 1.4 4.2 N 44.52 46.93 50 97.94 
19 Baby 36 F sister 70 no no 130/80 165 B 9.8 3 6 98 8.4 0.8 3.9 N 107.43 86.26 95 86 
20 dhanalakshmi 54 F mother 62 no no 110/80 170 B 8.9 2 7 160 13.9 1.2 4.1 N 52.46 49.76 51 82 
21 Uma 43 F mother 55 no no 126/70 110 O 10.7 1 2 90 13.9 1 3.9 N 62.98 64.32 69 83.59 
22 annammal 50 F mother 52 no no 110/80 135 AB 9.9 3 5 115 15.8 0.9 4 N 61.39 70.4 74 104 
23 Kaveri 42 F sister 58 no no 122/80 108 A 10.9 2 6 88 13.9 1.1 4.2 N 61 57.9 62 88 
24 rajathee 50 F mother 56 no no 136/82 98 B 9 1 4 92 9.9 1 4.2 N 59.5 62.38 66 107 
25 vasantha 54 F mother 60 no no 110/70 155 O 11.2 3 6 141 8.9 0.9 4.1 N 67.69 69.35 73 88 
S.N. NAME AGE SEX RELATION 
 
WT.KG  HT/DM F. H/O.R. D BP 
24 Hr 
UP Bl.G Hb BT  CT  RBS BUN S.Cr ALB USG C-G MDRD CKD-EPI DTPA  
26 dhanalakshmi 48 F mother 63 no no 136/80 130 B 10.1 1 3 109 8.9 0.9 4.4 N 76.03 71.03 76 85 
27 Vijaya 45 F mother 54 no no 110/72 105 O 11.3 2 7 143 13.9 1.2 4.6 N 50.47 51.63 55 80.16 
28 bhavani 55 F mother 58 no no 108/76 160 A 10.7 1 3 97 7.4 0.8 3.9 N 72.75 79.15 83 86 
29 chinnakulanthai 40 F sister 65 no no 130/76 95 B 9.3 3 4 130 13.9 1.2 4.5 N 63.95 52.88 57 88 
30 Emili 52 F mother 63 no no 120/80 130 AB 11.2 2 6 108 8.9 0.8 4 N 81.8 80.06 85 101 
31 Sathya 24 F daughter 51 no no 108/70 95 B 10.1 1 5 90 9.8 1.1 3.9 N 63.49 64.86 70 105 
32 raghupathy 51 M father 67 no no 130/80 125 A 9.8 2 4 140 11.4 0.8 4.1 N 103.52 108.32 103 107 
33 mamangam 45 M father 59 no no 124/80 180 B 11.9 2 3 124 8.8 0.9 4 N 86.5 96.99 103 119 
34 Rani 40 F sister 53 no no 110/70 90 O 10.9 3 3 156 13.2 1.2 4.3 N 52.14 52.88 57 82.47 
35 dhanalakshmi 50 F mother 57 no no 134/90 110 AB 11 2 4 89 11.8 1.1 3.8 N 55.06 55.88 59 93 
36 pambavasan 33 M son 61 no no 110/80 135 O 13.1 1 2 103 7.4 1 4.1 N 90.65 91.46 98 119 
37 rukmani 52 F mother 63 no no 140/80 160 O 12 2 6 93 7.9 1 3.9 N 65.45 61.88 65 80.41 
38 mayakrishnan 55 M father 59 no no 112/80 115 B 9.1 2 4 124 13.9 1.2 4 N 58.04 66.81 68 113 
39 Sridevi 27 F sister 51 no no 108/70 95 A 11.7 1 5 91 11.1 1.1 4.1 N 61.85 63.33 69 107 
40 narkalai 43 F sister 54 no no 120/76 140 O 10.3 2 6 165 7.6 0.9 4 N 68.71 72.63 79 101 
41 balasubramanian 44 M brother 58 no no 130/80 125 O 12.8 3 5 102 11 1.2 3.8 N 64.44 69.91 73 1 
42 Muthu 55 M father 61 no no 140/90 170 A 11.3 1 7 91 2 1.3 4.3 N 55.4 60.92 67 81.39 
43 madheshwari 31 F sister 57 no no 110/70 185 O 10.1 3 5 155 13.9 1 3.9 N 73.35 68.73 75 113 
44 baskaravalli 55 F mother 64 no no 130/80 135 B 9.9 2 4 183 8.9 1.1 4.1 N 58.38 54.81 57 97 
45 thiraviyam 54 M father 67 no no 116/80 160 O 11.9 1 6 111 9.9 1.2 3.7 N 66.69 67.06 68 93 
46 Amutha 45 F mother 58 no no 124/82 95 A 10.8 2 3 170 7.4 1 4 N 65.05 63.73 68 122 
47 jeyalakshmi 38 F sister 62 no no 116/76 175 O 12.4 3 4 134 7.6 0.9 3.8 N 79.7 72.98 79 115 
48 ramarajan 29 M brother 61 no no 110/80 130 B 13.1 3 4 89 13.2 0.9 4.1 N 104.5 106 115 107 
49 manikandan 50 M father 64 no no 130/84 108 B 10.7 2 5 161 7.1 0.9 4.2 N 88.89 94.93 98 93 
50 chandran 38 M brother 59 no no 120/80 165 AB 13.5 1 6 101 15.1 1.1 3.8 N 75.98 79.63 92 113 
KEY WORDS FOR  MASTER CHART 
W t.                             - weight in kg 
HT/DM                      - past history of hypertension and diabetes 
F.H/O. RD                 - family history of renal disease 
BP                              - blood pressure 
24HR UP                   - 24 hour urine protein 
Bl.G                           - blood group 
Hb                              - hemoglobin 
BT                              - bleeding time 
CT                             - clotting time 
BUN                         - blood urea nitrogen 
S.Cr                          - serum creatinine 
Alb                           - albumin 
USG                         - ultrasonogram 
C-G                          - GFR by cockcroft gault formula 
